Skip Navigation LinksHome > May 2013 - Volume 32 - Issue 5 > Effects of Corneal Cross-linking on Contrast Sensitivity, Vi...
doi: 10.1097/ICO.0b013e31826672e2
Clinical Science

Effects of Corneal Cross-linking on Contrast Sensitivity, Visual Acuity, and Corneal Topography in Patients With Keratoconus

Lamy, Ricardo MD, PhD*,†; Netto, Camila F. MD*; Reis, Ricardo G. MD*; Procopio, Bruno MD*; Porco, Travis C. PhD, MPH; Stewart, Jay M. MD; Dantas, Adalmir M. MD, PhD*; Moraes, Haroldo V. Jr MD, PhD*

Collapse Box


Purpose: To assess the effects of corneal collagen cross-linking (CXL) on contrast sensitivity (CS), visual acuity, and corneal topography investigating possible predictors of efficacy.

Methods: Sixty-eight eyes of 34 patients with progressive keratoconus were enrolled in this prospective study. CXL was performed in one eye and the other eye was left untreated as a control. CS, best spectacle–corrected visual acuity (BSCVA), simulated keratometry in the steepest meridian (SimK-s), mean power in the central 3-mm zone (C-MP), mean power in the paracentral 3- to 5-mm zone (P-MP), maximum keratometric power in the central zone (C-Kmax), and maximum keratometric power in the paracentral zone (P-Kmax) were evaluated at baseline, 40 days, 3 months, 6 months, 1 year, and after 2 years of follow-up.

Results: Treated eyes showed an improvement (P < 0.001) of +0.16 logCS and −0.16 logarithm of the minimum angle of resolution (logMAR) and a reduction in SimK-s of −0.61 diopter (D), C-Kmax −1.11 D, P-Kmax −0.99 D, C-MP −0.39 D, and P-MP −0.30 D. Of the treated eyes, 43.3% had a decrease in C-Kmax greater than 1 D, 50% by 0 to 0.99 D, and 6.7% had an increase of up to +0.89 D. Treated eyes with keratometric apex in the central 3-mm zone (CKA) improved BSCVA −0.19 logMAR and CS +0.19 logCS; whereas in treated eyes with paracentral keratometric apex (PKA), the improvement was −0.13 logMAR and +0.16 logCS.

Conclusions: CXL with riboflavin and UV-A improved CS and inhibited the progression of keratoconus. As a predictor of treatment efficacy, eyes with CKA showed greater improvement in BSCVA after CXL when compared with eyes with PKA.

© 2013 by Lippincott Williams & Wilkins.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.